CAR-T Meeting 2021 | CAR-T patient experience: results from the Global Patient Survey
Lorna Warwick
• 8 Feb 2021
Lorna Warwick, Lymphoma Coalition, Toronto, Canada, discusses the Lymphoma Coalition Bi-Annual Global Patient Survey and the small-scale results of patients that have undergone CAR T-cell therapy. Ms Warwick highlights the differences in the dataset between patients who were qualified for CAR-T therapy but had not yet received it and those that had completed CAR T-cell therapy, as well as the impact of CAR T-cell therapy on patients’ mental health. Ms Warwick also suggests educating patients about CAR T-cell therapy could help address these problems. This interview took place during the 3rd European CAR T-cell Meeting.
